12/20/2021Xpovio Combo Conditionally Approved in China for Repeatedly Treated rr...

12/20/2021Cytokinetics and Ji Xing Expand Collaboration for Omecamtiv Mecarbil i...

12/17/2021CBMG Cleared of U.S. IND of Bi-Specific CAR-T Cell Therapy C-CAR039...

12/17/2021BioMarin and Skyline Therapeutics in Deal to Co-develop Novel Gene The...

12/17/2021IQVIA: Chinese Retail Pharmacy Sales Up Only 0.3% in Q3/2021

12/17/2021Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...

12/17/2021The IPO Plans of 16 Chinese Medpharm Startups Failed to Win SSE STAR A...

12/17/2021Data Snapshot – The Landscape of Innovative Biologics in China

12/17/2021Recent Executive Moves

12/16/2021US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...

12/16/2021Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...

12/16/2021US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...

12/15/2021BeiGene Plunges at Shanghai STAR Debut as Risks Overshadow

12/15/2021China Biopharma, Tech Stocks Fall on Reports of Expanded U.S. Sanction...

12/15/2021New Study: China Healthcare under Remaking in Digital Era

12/15/2021Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)

12/15/2021Barrons: Chinese Biotechs Could End Up on U.S. Blacklists

12/15/2021PharmaDJ's China NMPA Approval Tracker: May 2021

12/14/2021Comparing Drug Patent Linkage in China and the US

12/14/2021Antengene Enters Clinical Collaboration with BMS to Evaluate ATG-017 i...

12/14/2021Everest Med and Providence Therapeutics Join Hands to Co-develop Vacci...

12/14/2021Sciwind Bio Acquires Global, Exclusive Rights for Sanofi's GIP Recepto...

12/14/2021China Issues the Provisions for National Pharmaceutical Reserve (2021 ...

12/14/2021BeiGene Licenses Ex-China Rights of Anti-LAG-3 Antibody LBL-007 from N...

12/14/2021Innovent Announces Positive Pivotal Phase 2 Results for Parsaclisib (...

12/13/2021IQVIA: Chinese Hospital Drug Market Growth Slowed to 2.7% in Q3/2021

12/13/2021NMPA Withdraws Approvals of 210 Domestic Drug Products

12/13/2021Lilly and Regor Therapeutics Enter $1.5B Strategic Deal for Novel Meta...

12/13/2021BioInvent and CASI Announce Chinese CTA Approval for NHL Drug BI-1206

12/13/2021Universe and Kitanihon Enter Strategic Deal with Plan for Kampo Man...

Page:179/797 Total number of articles:23898: [First][<<] [177] [178] [179] [180] [181] [>>] [End]